• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Ingredion Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    2/4/25 6:07:44 AM ET
    $INGR
    Packaged Foods
    Consumer Staples
    Get the next $INGR alert in real time by email
    ingr-20250204
    0001046257false00010462572025-02-042025-02-04

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, DC 20549
    FORM 8-K
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of
    The Securities Exchange Act of 1934
    Date of report (Date of earliest event reported): February 4, 2025
    Ingredion_Logo_SM_rgbHEX.gif
    INGREDION INCORPORATED
    (Exact name of registrant as specified in its charter)
    Delaware1-1339722-3514823
    (State or other jurisdiction
    of incorporation)
    (Commission
    File Number)
    (IRS Employer
    Identification No.)
    5 Westbrook Corporate Center, Westchester, Illinois
    60154
    (Address of principal executive offices)(Zip Code)
    (708) 551-2600
    (Registrant’s telephone number, including area code)
    Not Applicable
    (Former name or former address, if changed since last report)
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
    [ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    SEC 873 (07-24)Potential persons who are to respond to the collection of information contained in this Form are not required to respond unless the Form displays a currently valid OMB control number.
    Securities registers pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common Stock, par value $0.01 per shareINGRNew York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company o
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o



    Item 2.02    Results of Operations and Financial Condition.
    On February 4, 2025, Ingredion Incorporated (the “Company”) issued a press release announcing the Company’s condensed consolidated financial results for the year ended December 31, 2024 (the “Press Release”). A copy of the Company’s Press Release is being furnished as Exhibit 99 and hereby incorporated by reference. The Company will conduct a conference call Tuesday, February 4, 2025 at 8:00 a.m. CT to discuss the fourth quarter and year-end financial results.
    The information contained in Item 2.02 of this report on Form 8-K, including Exhibit 99, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933 or the Exchange Act.
    Item 9.01    Financial Statements and Exhibits.
    (d) Exhibits
    The following exhibit is being furnished as part of this report:
    Exhibit NumberDescription
    99
    Press Release dated February 4, 2025 issued by Ingredion Incorporated
    104Cover Page Interactive Data File (the cover page XBRL tags are embedded in the Inline XBRL document).



    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    INGREDION INCORPORATED
    Date:February 4, 2025By:/s/ James D. Gray
    James D. Gray
    Executive Vice President and Chief Financial Officer

    Get the next $INGR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $INGR

    DatePrice TargetRatingAnalyst
    4/7/2025$145.00Buy → Neutral
    UBS
    8/9/2024$122.00 → $145.00Equal Weight → Overweight
    Barclays
    2/15/2024$122.00 → $135.00Neutral → Buy
    Goldman
    9/29/2023$120.00Outperform
    Oppenheimer
    4/14/2023$115.00Market Perform
    BMO Capital Markets
    4/13/2023$105.00 → $121.00Neutral → Buy
    UBS
    1/23/2023$105.00 → $110.00Overweight → Equal Weight
    Barclays
    1/17/2023$100.00 → $120.00Equal-Weight → Overweight
    Stephens
    More analyst ratings